Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 694

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group

Open access
Al-Shamsi, Humaid O., Alhazzani, Waleed, Alhuraiji, Ahmad, Coomes, Eric A., Chemaly, Roy F., Almuhanna, Meshari, Wolff, Robert A., Ibrahim, Nuhad K., Chua, Melvin L.K., Hotte, Sebastien J., Meyers, Brandon M., Elfiki, Tarek, Curigliano, Giuseppe, Eng, Cathy, Grothey, Axel, Xie, Conghua·2020·The Oncologist

Abstract

The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread globally since being identified as a public health emergency of major international concern and has now been declared a pandemic by the World Health Organization (WHO). In December 2019, an outbreak of atypical pneumonia, known as COVID-19, was identified in Wuhan, China. The newly identified zoonotic coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is characterized by rapid human-to-human transmission. Many cancer patients frequently visit the hospital for treatment and disease surveillance. They may be immunocompromised due to the underlying malignancy or anticancer therapy and are at higher risk of developing infections. Several factors increase the risk of infection, and cancer patients commonly have multiple risk factors. Cancer patients appear to have an estimated twofold increased risk of contracting SARS-CoV-2 than the general population. With the WHO declaring the novel coronavirus outbreak a pandemic, there is an urgent need to address the impact of such a pandemic on cancer patients. This include changes to resource allocation, clinical care, and the consent process during a pandemic. Currently and due to limited data, there are no international guidelines to address the management of cancer patients in any infectious pandemic. In this review, the potential challenges associated with managing cancer patients during the COVID-19 infection pandemic will be addressed, with suggestions of some practical approaches. Implications for Practice: The main management strategies for treating cancer patients during the COVID-19 epidemic include clear communication and education about hand hygiene, infection control measures, high-risk exposure, and the signs and symptoms of COVID-19. Consideration of risk and benefit for active intervention in the cancer population must be individualized. Postponing elective surgery or adjuvant chemotherapy for cancer patients with low risk of progression should be considered on a case-by-case basis. Minimizing outpatient visits can help to mitigate exposure and possible further transmission. Telemedicine may be used to support patients to minimize number of visits and risk of exposure. More research is needed to better understand SARS-CoV-2 virology and epidemiology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1634/theoncologist.2020-0213

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 10

  1. Battershill, 2006, Influenza pandemic planning for cancer patients, Curr Oncol, 13, 119, 10.3390/curroncol13040012 · doi:10.3390/curroncol13040012
  2. Willan, 2020, Care of haematology patients in a COVID-19 epidemic, Br J Haematol
  3. Mukherjee, 2003, Hiding in the bunker: Challenges for a radiation oncology department operating in the severe acute respiratory syndrome outbreak, Australas Radiol, 47, 143, 10.1046/j.0004-8461.2003.01165.x · doi:10.1046/j.0004-8461.2003.01165.x
  4. Shereen, 2019, Delivering chemotherapy at home: How much do we know?, Br nursing Community Nurs, 24, 482, 10.12968/bjcn.2019.24.10.482 · doi:10.12968/bjcn.2019.24.10.482
  5. Warr, 2013, Baseline blood work before initiation of chemotherapy: What is safe in the real world?, J Oncol Pract, 9, e182, 10.1200/JOP.2012.000719 · doi:10.1200/jop.2012.000719
  6. Yang, 2020, Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID-19) [in Chinese], Zhonghua Zhong Liu Za Zhi, 42
  7. Ohrmalm, 2010, Flocked nasal swab versus nasopharyngeal aspirate for detection of respiratory tract viruses in immunocompromised adults: A matched comparative study, BMC Infect Dis, 10, 340, 10.1186/1471-2334-10-340 · doi:10.1186/1471-2334-10-340
  8. Sim, 2018, Viral respiratory tract infections in allogeneic hematopoietic stem cell transplantation recipients in the era of molecular testing, Biol Blood Marrow Transplant, 24, 1490, 10.1016/j.bbmt.2018.03.004 · doi:10.1016/j.bbmt.2018.03.004
  9. Chemaly, 2014, Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies, Clin Infect Dis, 59, S344, 10.1093/cid/ciu623 · doi:10.1093/cid/ciu623
  10. The Medical Journal of Australia

Cited by

See all 694

Metadata

Authors
Al-Shamsi, H. O., Alhazzani, W., Alhuraiji, A., Coomes, E. A., Chemaly, R. F., Almuhanna, M., Wolff, R. A., Ibrahim, N. K., Chua, M. L. K., Hotte, S. J., Meyers, B. M., Elfiki, T., Curigliano, G., Eng, C., Grothey, A., & Xie, C.
Venue
The Oncologist
Published
2020-04-27
Volume
25
Issue
6
Pages
e936-e945
ISSN
  • 1083-7159 (ISSN-L)
  • 1549-490X
OpenAlex
W3014319236
Cited by
694
References
40
FWCI
50.53
Type
journal article
Language
en
Open access
hybrid
Funders
  • F. Hoffmann-La Roche
  • Khalifa Foundation - Abu Dhabi - United Arab Emirates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. https://app.cochat.ai/papers/10.1634/theoncologist.2020-0213
The paper
Al-Shamsi, H. O., Alhazzani, W., Alhuraiji, A., Coomes, E. A., Chemaly, R. F., Almuhanna, M., Wolff, R. A., Ibrahim, N. K., Chua, M. L. K., Hotte, S. J., Meyers, B. M., Elfiki, T., Curigliano, G., Eng, C., Grothey, A., & Xie, C. (2020). A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. The Oncologist. https://doi.org/10.1634/theoncologist.2020-0213

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.